Tony Dickherber

National Cancer Institute

High Definition Biology: Technologies Advancing Cancer Research and Diagnostics

Tony Dickherber, SLAS Committee member, and Program Director at the National Cancer Institute (NCI), discusses emerging technologies in cancer diagnostics and monitoring, including high-speed, high-throughput, multiplex assays, and how they contribute to developing effective cancer treatments.



LIKE 0
Tony Dickherber
Cancer Research SLAS2019

Tony Dickherber

Biography

Tony Dickherber is Director of the National Cancer Institute’s (NCI) Innovative Molecular Analysis Technologies program More

Tony Dickherber

National Cancer Institute

Tony Dickherber is a Program Director of the National Cancer Institute’s (NCI) Center for Strategic Scientific Initiatives, and Director of the NCI Innovative Molecular Analysis Technologies program. The NCI Innovative Molecular Analysis Technologies program focuses exclusively on early stage technology development to address unmet needs in the cancer research arena.